Gras-Masse H - Search Results

1

Lipopeptide presentation pathway in dendritic cells.

Hosmalin A, Andrieu M, Loing E, Desoutter JF, Hanau D, Gras-Masse H, Dautry-Varsat A, Guillet JG. Hosmalin A, et al. Immunol Lett. 2001 Nov 1;79(1-2):97-100. doi: 10.1016/s0165-2478(01)00271-1. Immunol Lett. 2001. PMID: 11595295

2

Evaluation of SIV-lipopeptide immunizations administered by the intradermal route in their ability to induce antigen specific T-cell responses in rhesus macaques.

Coutsinos Z, Villefroy P, Gras-Masse H, Guillet JG, Bourgault-Villada I. Coutsinos Z, et al. Among authors: gras masse h. FEMS Immunol Med Microbiol. 2005 Mar 1;43(3):357-66. doi: 10.1016/j.femsim.2004.09.003. FEMS Immunol Med Microbiol. 2005. PMID: 15708309 Free article.

3

Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8(+) T lymphocyte activation.

Andrieu M, Loing E, Desoutter JF, Connan F, Choppin J, Gras-Masse H, Hanau D, Dautry-Varsat A, Guillet JG, Hosmalin A. Andrieu M, et al. Eur J Immunol. 2000 Nov;30(11):3256-65. doi: 10.1002/1521-4141(200011)30:11<3256::AID-IMMU3256>3.0.CO;2-H. Eur J Immunol. 2000. PMID: 11093141 Free article.

4

Extension of HLA-A*0201-restricted minimal epitope by N epsilon-palmitoyl-lysine increases the life span of functional presentation to cytotoxic T cells.

Loing E, Andrieu M, Thiam K, Schörner D, Wiesmüller KH, Hosmalin A, Jung G, Gras-Masse H. Loing E, et al. J Immunol. 2000 Jan 15;164(2):900-7. doi: 10.4049/jimmunol.164.2.900. J Immunol. 2000. PMID: 10623838

5

Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal study.

Le Gal FA, Prevost-Blondel A, Lengagne R, Bossus M, Farace F, Chaboissier A, Gras-Masse H, Engelhard VH, Guillet JG, Gahéry-Ségard H. Le Gal FA, et al. Int J Cancer. 2002 Mar 10;98(2):221-7. doi: 10.1002/ijc.10186. Int J Cancer. 2002. PMID: 11857412

6

Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: characterization of CD8+-T-cell epitopes recognized.

Gahéry-Ségard H, Pialoux G, Figueiredo S, Igéa C, Surenaud M, Gaston J, Gras-Masse H, Lévy JP, Guillet JG. Gahéry-Ségard H, et al. J Virol. 2003 Oct;77(20):11220-31. doi: 10.1128/jvi.77.20.11220-11231.2003. J Virol. 2003. PMID: 14512570 Free PMC article. Clinical Trial.

7

Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein.

Martinon F, Gras-Masse H, Boutillon C, Chirat F, Deprez B, Guillet JG, Gomard E, Tartar A, Levy JP. Martinon F, et al. J Immunol. 1992 Nov 15;149(10):3416-22. J Immunol. 1992. PMID: 1385524

8

Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides.

Sauzet JP, Déprez B, Martinon F, Guillet JG, Gras-Masse H, Gomard E. Sauzet JP, et al. Vaccine. 1995 Oct;13(14):1339-45. doi: 10.1016/0264-410x(94)00087-4. Vaccine. 1995. PMID: 8585291

9

Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptides.

Sauzet JP, Gras-Masse H, Guillet JG, Gomard E. Sauzet JP, et al. Int Immunol. 1996 Apr;8(4):457-65. doi: 10.1093/intimm/8.4.457. Int Immunol. 1996. PMID: 8671632

10

Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine.

Mortara L, Letourneur F, Gras-Masse H, Venet A, Guillet JG, Bourgault-Villada I. Mortara L, et al. J Virol. 1998 Feb;72(2):1403-10. doi: 10.1128/JVI.72.2.1403-1410.1998. J Virol. 1998. PMID: 9445041 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters